Targocil
Product Specifications
UNSPSC Description
Targocil functions as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) with MIC90s of 2 μg/ mL for both MRSA and MSSA.
Target Antigen
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Targocil.html
Purity
98.84
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
COC1=CC2=C(C=C1OC)C(N(CC)CC)=NC3=C(S(=O)(C4=CC=C(Cl)C=C4)=O)N=NN32
Molecular Weight
475.95
References & Citations
[1]Suzuki T, et al. In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2011 Feb;55(2):767-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-18702/Targocil-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-18702/Targocil-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1200443-21-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1231266-01 0.02 mg (E-Coli)
Recombinant Cellvibrio japonicus UPF0345 protein CJA_1969 (CJA_1969)
Ask
View Details MBS1231266-02 0.1 mg (E-Coli)
Recombinant Cellvibrio japonicus UPF0345 protein CJA_1969 (CJA_1969)
Ask
View Details MBS1231266-03 0.02 mg (Yeast)
Recombinant Cellvibrio japonicus UPF0345 protein CJA_1969 (CJA_1969)
Ask
View Details